chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Her oncologist postponed the second dose; earache; bumps behind ears; severe sore throat feeling like two balls inside her throat; Injection site pain; Vaccination site bump and swelling; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (earache), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Vaccination site bump and swelling), EAR DISCOMFORT (bumps behind ears) and OROPHARYNGEAL PAIN (severe sore throat feeling like two balls inside her throat) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PHENYTOIN SODIUM (DILANTIN D.A.) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain) and VACCINATION SITE SWELLING (Vaccination site bump and swelling). On 24-Mar-2021, the patient experienced EAR PAIN (earache), EAR DISCOMFORT (bumps behind ears) and OROPHARYNGEAL PAIN (severe sore throat feeling like two balls inside her throat). On an unknown date, the patient experienced OFF LABEL USE (Her oncologist postponed the second dose). On 26-Mar-2021, EAR PAIN (earache), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Vaccination site bump and swelling), EAR DISCOMFORT (bumps behind ears) and OROPHARYNGEAL PAIN (severe sore throat feeling like two balls inside her throat) had resolved. At the time of the report, OFF LABEL USE (Her oncologist postponed the second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details include Benadryl cream for itching Ibuprofen for earache at ER Other Concomitant Medication was Zonosimide and radiotherapy( for Cancer).
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling hot, Myalgia, Nasopharyngitis
Clinical narrative: hot; temperature; cold; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot), BODY TEMPERATURE (temperature), NASOPHARYNGITIS (cold) and MYALGIA (body aches) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced FEELING HOT (hot), BODY TEMPERATURE (temperature), NASOPHARYNGITIS (cold) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, FEELING HOT (hot), BODY TEMPERATURE (temperature), NASOPHARYNGITIS (cold) and MYALGIA (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: did not received 2nd dose yet, (Day 55); This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (did not received 2nd dose yet, (Day 55)) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (did not received 2nd dose yet, (Day 55)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (did not received 2nd dose yet, (Day 55)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not reported. Treatment information as not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Urticaria
Clinical narrative: Hives; Itchiness; Red bumps breaking out in arm, between thighs, breast, back of leg; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PRURITUS (Itchiness) and RASH ERYTHEMATOUS (Red bumps breaking out in arm, between thighs, breast, back of leg) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METHOTREXATE, PREDNISONE, FOLIC ACID and LISINOPRIL for an unknown indication.    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced URTICARIA (Hives), PRURITUS (Itchiness) and RASH ERYTHEMATOUS (Red bumps breaking out in arm, between thighs, breast, back of leg). At the time of the report, URTICARIA (Hives), PRURITUS (Itchiness) and RASH ERYTHEMATOUS (Red bumps breaking out in arm, between thighs, breast, back of leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication provided included cream for itchiness.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: patient have a migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (patient have a migraine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since 2000 and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE for Thyroid disorder NOS.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced MIGRAINE (patient have a migraine). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Migraine, at a dose of 2 dosage form. At the time of the report, MIGRAINE (patient have a migraine) had resolved. Not Provided          Action taken with vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Reporter's address was updated. Patient's demographics were added. Information about both the doses of Moderna vaccine was updated. Medical history, concomitant medications and treatment medications were added. Outcome of the event was updated from unknown to recovered.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: tinnitus flare in left ear; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus flare in left ear) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus flare in left ear). At the time of the report, TINNITUS (tinnitus flare in left ear) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided by the reporter.  No treatment information was provided by the reporter.  Upon internal review on 04-AUG-2021, the age was corrected to 45 years.   This case was linked to MOD-2021-092027 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose received after 50-52 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received after 50-52 days after 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received after 50-52 days after 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received after 50-52 days after 1st dose) had resolved. Not Provided          No concomitant medication provided. No treatment information mentioned.   This case was linked to MOD-2021-033525.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up received on 29 Jun 2021 included no new information (email address added).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in the left ear, tinnitus in same side vaccine was administered; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the left ear, tinnitus in same side vaccine was administered) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in the left ear, tinnitus in same side vaccine was administered). At the time of the report, TINNITUS (Ringing in the left ear, tinnitus in same side vaccine was administered) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. The treatment involved Flonase, Antihistamine to relieve the symptoms.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Treatment medications was not provided    Reporter did not allow further contact
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Swelling
Clinical narrative: Look like chicken pots all over body and itchy; Never had that kind of rash; Had a little tiny bump; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING (Had a little tiny bump), PRURITUS (Look like chicken pots all over body and itchy) and RASH (Never had that kind of rash) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORATADINE (CLARITINE) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced SWELLING (Had a little tiny bump). On 15-Apr-2021, the patient experienced PRURITUS (Look like chicken pots all over body and itchy) and RASH (Never had that kind of rash). At the time of the report, SWELLING (Had a little tiny bump), PRURITUS (Look like chicken pots all over body and itchy) and RASH (Never had that kind of rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she was taking medication that will end on 4-29-2021. Patient went hospital and received medication .No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed the second dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: administrator of the vaccine might have given a double dose of the shot, seems as if syringe has; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (administrator of the vaccine might have given a double dose of the shot, seems as if syringe has) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced ACCIDENTAL OVERDOSE (administrator of the vaccine might have given a double dose of the shot, seems as if syringe has). At the time of the report, ACCIDENTAL OVERDOSE (administrator of the vaccine might have given a double dose of the shot, seems as if syringe has) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Fatigue, Joint swelling, Lymphadenopathy, Pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (lot of pain, it was very intense in the waist), PAIN IN EXTREMITY (lot of pain, it was very intense in the legs), LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen) and PAIN IN EXTREMITY (intense pain in the forearm up to the fingers) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (lot of pain, it was very intense in the waist) and PAIN IN EXTREMITY (lot of pain, it was very intense in the legs). On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen), PAIN IN EXTREMITY (intense pain in the forearm up to the fingers), BREAST PAIN (pain in the breast), PAIN IN EXTREMITY (pain in the legs, specially in the interior part of the knees), PARAESTHESIA (tingling sensation in the body), FATIGUE (tired) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (lot of pain, it was very intense in the waist), PAIN IN EXTREMITY (lot of pain, it was very intense in the legs), LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen), PAIN IN EXTREMITY (intense pain in the forearm up to the fingers), BREAST PAIN (pain in the breast), PAIN IN EXTREMITY (pain in the legs, specially in the interior part of the knees), PARAESTHESIA (tingling sensation in the body), FATIGUE (tired) and PYREXIA (fever) outcome was unknown. Not Provided          This case was linked to MOD-2021-092168 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (lot of pain, it was very intense in the waist), PAIN IN EXTREMITY (lot of pain, it was very intense in the legs), LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen) and PAIN IN EXTREMITY (intense pain in the forearm up to the fingers) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (lot of pain, it was very intense in the waist) and PAIN IN EXTREMITY (lot of pain, it was very intense in the legs). On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen), PAIN IN EXTREMITY (intense pain in the forearm up to the fingers), BREAST PAIN (pain in the breast), PAIN IN EXTREMITY (pain in the legs, specially in the interior part of the knees), PARAESTHESIA (tingling sensation in the body), FATIGUE (tired) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (lot of pain, it was very intense in the waist), PAIN IN EXTREMITY (lot of pain, it was very intense in the legs), LYMPHADENOPATHY (swollen lymph nodes in the injection arm), JOINT SWELLING (interior parts of both elbows were swollen), PAIN IN EXTREMITY (intense pain in the forearm up to the fingers), BREAST PAIN (pain in the breast), PAIN IN EXTREMITY (pain in the legs, specially in the interior part of the knees), PARAESTHESIA (tingling sensation in the body), FATIGUE (tired) and PYREXIA (fever) outcome was unknown. Not Provided          This case was linked to MOD-2021-092168 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Dyspnoea, Fatigue, Myalgia, Nasal congestion
Clinical narrative: Loss of smell; Congestion on  nose; Very thick phlegm; Difficult to breath; Tiredness; Body ache; Felt like he was running a fever; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Loss of smell), NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath) and FATIGUE (Tiredness) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Diabetes.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced ANOSMIA (Loss of smell), NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Felt like he was running a fever). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) at an unspecified dose and frequency. On 26-Apr-2021, ANOSMIA (Loss of smell) had resolved. At the time of the report, NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Felt like he was running a fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication for blood pressure, diabetes and cardiovascular system.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia
Clinical narrative: Loss of smell; Congestion on  nose; Very thick phlegm; Difficult to breath; Tiredness; Body ache; Felt like he was running a fever; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Loss of smell), NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath) and FATIGUE (Tiredness) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Diabetes.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced ANOSMIA (Loss of smell), NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Felt like he was running a fever). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) at an unspecified dose and frequency. On 26-Apr-2021, ANOSMIA (Loss of smell) had resolved. At the time of the report, NASAL CONGESTION (Congestion on  nose), PRODUCTIVE COUGH (Very thick phlegm), DYSPNOEA (Difficult to breath), FATIGUE (Tiredness), MYALGIA (Body ache) and PYREXIA (Felt like he was running a fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication for blood pressure, diabetes and cardiovascular system.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster
Clinical narrative: was diagnosed with shingles; severe fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (was diagnosed with shingles) and FATIGUE (severe fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced HERPES ZOSTER (was diagnosed with shingles) and FATIGUE (severe fatigue). At the time of the report, HERPES ZOSTER (was diagnosed with shingles) and FATIGUE (severe fatigue) outcome was unknown.            No concomitant medications were provided. Treatment with Antibiotics(not specified) for the pertained events, was provided by the patient.   This case was linked to MOD-2021-092011 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Reporters contact information was added
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster, Hypersomnia, Migraine, Off label use
Clinical narrative: heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine; severe migraine that wouldn't go away for over 24 hours; Shingles; sore arm; tiredness; slept most of the day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSOMNIA (slept most of the day), OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine), MIGRAINE (severe migraine that wouldn't go away for over 24 hours), HERPES ZOSTER (Shingles) and PAIN IN EXTREMITY (sore arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No historical conditions were reported.  Concomitant products included METOPROLOL SUCCINATE for Arrhythmia, DICYCLOMINE HCL for Diarrhea, PANTOPRAZOLE for GERD, Acid reflux (esophageal), Gastritis and Stomach upset, POTASSIUM CHLORIDE for Low potassium syndrome, ERENUMAB AOOE (AIMOVIG [ERENUMAB AOOE]) for Migraine, TOPIRAMATE and RIZATRIPTAN BENZOATE (RIZATRIPTAN ODT) for Migraine prophylaxis, TIZANIDINE for Muscle relaxant, ONDANSETRON (ZOFRAN MELT) for Nausea, TRAMADOL for Pain, ACETYLSALICYLIC ACID (BABY ASPIRIN) for Prevention and Prevention.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HYPERSOMNIA (slept most of the day), PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness). On 23-Mar-2021, the patient experienced MIGRAINE (severe migraine that wouldn't go away for over 24 hours) and HERPES ZOSTER (Shingles). On an unknown date, the patient experienced OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes zoster, at a dose of 1 gram; PREDNISONE for Shingles, at a dose of 20 mg and CLOBETASOL PROPIONATE for Shingles, at a dose of 0.05 percent. On 22-Mar-2021, HYPERSOMNIA (slept most of the day) had resolved. At the time of the report, OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine), PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness) outcome was unknown and MIGRAINE (severe migraine that wouldn't go away for over 24 hours) and HERPES ZOSTER (Shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She stated her healthcare provider has told her that she cannot have the second dose of the Moderna COVID-19 Vaccine.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine; severe migraine that wouldn't go away for over 24 hours; Shingles; sore arm; tiredness; slept most of the day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSOMNIA (slept most of the day), OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine), MIGRAINE (severe migraine that wouldn't go away for over 24 hours), HERPES ZOSTER (Shingles) and PAIN IN EXTREMITY (sore arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No historical conditions were reported.  Concomitant products included METOPROLOL SUCCINATE for Arrhythmia, DICYCLOMINE HCL for Diarrhea, PANTOPRAZOLE for GERD, Acid reflux (esophageal), Gastritis and Stomach upset, POTASSIUM CHLORIDE for Low potassium syndrome, ERENUMAB AOOE (AIMOVIG [ERENUMAB AOOE]) for Migraine, TOPIRAMATE and RIZATRIPTAN BENZOATE (RIZATRIPTAN ODT) for Migraine prophylaxis, TIZANIDINE for Muscle relaxant, ONDANSETRON (ZOFRAN MELT) for Nausea, TRAMADOL for Pain, ACETYLSALICYLIC ACID (BABY ASPIRIN) for Prevention and Prevention.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HYPERSOMNIA (slept most of the day), PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness). On 23-Mar-2021, the patient experienced MIGRAINE (severe migraine that wouldn't go away for over 24 hours) and HERPES ZOSTER (Shingles). On an unknown date, the patient experienced OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes zoster, at a dose of 1 gram; PREDNISONE for Shingles, at a dose of 20 mg and CLOBETASOL PROPIONATE for Shingles, at a dose of 0.05 percent. On 22-Mar-2021, HYPERSOMNIA (slept most of the day) had resolved. At the time of the report, OFF LABEL USE (heathcare provider has told her she cannot have the second dose of the Moderna COVID-19 Vaccine), PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness) outcome was unknown and MIGRAINE (severe migraine that wouldn't go away for over 24 hours) and HERPES ZOSTER (Shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She stated her healthcare provider has told her that she cannot have the second dose of the Moderna COVID-19 Vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose of vaccine is been administered two weeks after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine is been administered two weeks after the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine is been administered two weeks after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine is been administered two weeks after the first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medications were provided No  Concomitant medications were provided
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: After getting  second shot of the vaccine, they developed swelling of the face; Afyter getting their second shot of vaccine vaccine, they developed hives of the face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (After getting  second shot of the vaccine, they developed swelling of the face) and URTICARIA (Afyter getting their second shot of vaccine vaccine, they developed hives of the face) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (After getting  second shot of the vaccine, they developed swelling of the face) and URTICARIA (Afyter getting their second shot of vaccine vaccine, they developed hives of the face). At the time of the report, SWELLING FACE (After getting  second shot of the vaccine, they developed swelling of the face) and URTICARIA (Afyter getting their second shot of vaccine vaccine, they developed hives of the face) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was reported getting knee replacement on 12-APR-2021. Patient consulted emergency room  for treatment but treatment data was not provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: received both doses of the Moderna Covid-19 vaccine while pregnant; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the Moderna Covid-19 vaccine while pregnant) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 13-Jan-2021 and the estimated date of delivery was 20-Oct-2021. On 27-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the Moderna Covid-19 vaccine while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  On 27-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (received both doses of the Moderna Covid-19 vaccine while pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported. Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received on 27-APR-2021 and does not contain any new information
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site red after 1st dose; Injection site swollen after 1st dose; Injection site hot to the touch after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site red after 1st dose), VACCINATION SITE WARMTH (Injection site hot to the touch after 1st dose) and VACCINATION SITE SWELLING (Injection site swollen after 1st dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site red after 1st dose), VACCINATION SITE WARMTH (Injection site hot to the touch after 1st dose) and VACCINATION SITE SWELLING (Injection site swollen after 1st dose). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site red after 1st dose), VACCINATION SITE WARMTH (Injection site hot to the touch after 1st dose) and VACCINATION SITE SWELLING (Injection site swollen after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure inadequately controlled, Headache
Clinical narrative: Blood pressure out of whack; Having headache everyday; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INADEQUATELY CONTROLLED (Blood pressure out of whack) and HEADACHE (Having headache everyday) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INADEQUATELY CONTROLLED (Blood pressure out of whack) and HEADACHE (Having headache everyday). At the time of the report, BLOOD PRESSURE INADEQUATELY CONTROLLED (Blood pressure out of whack) and HEADACHE (Having headache everyday) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  The treatment information was not provided.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Gait inability, Pain in extremity
Clinical narrative: Couldn't walk or even go to the pool.Mostly rested; Terrible fatigue; Shoulder blader pain; Shortness of breath; Soreness in the arm; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm), GAIT INABILITY (Couldn't walk or even go to the pool.Mostly rested), DYSPNOEA (Shortness of breath), FATIGUE (Terrible fatigue) and ARTHRALGIA (Shoulder blader pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). On 16-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath) and ARTHRALGIA (Shoulder blader pain). On 18-Apr-2021, the patient experienced GAIT INABILITY (Couldn't walk or even go to the pool.Mostly rested) and FATIGUE (Terrible fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 12-Apr-2021, PAIN IN EXTREMITY (Soreness in the arm) had resolved. On 24-Apr-2021, DYSPNOEA (Shortness of breath) and ARTHRALGIA (Shoulder blader pain) had resolved. On 25-Apr-2021, GAIT INABILITY (Couldn't walk or even go to the pool.Mostly rested) and FATIGUE (Terrible fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported  Treatment medication were also include cold care medication
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment medication were provided.   This case was linked to MOD-2021-092150 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Followup received on 25-MAY-2021 included No newinformation.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Diarrhoea, Dyspnoea, Erythema
Clinical narrative: Itching; abdomen is so swollen and distended; redness; Swelling face; tight throat; Sick; Diarrhea; vomiting; Fever; Headache; Muscle pain; Chills; used her inhaler 2 to 3 times; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included ONDANSETRON HYDROCHLORIDE (ZOFRAN) for Nausea, SALBUTAMOL (ALBUTEROL) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ILLNESS (Sick), DIARRHOEA (Diarrhea), SWELLING FACE (Swelling face), THROAT TIGHTNESS (tight throat), DYSPNOEA (used her inhaler 2 to 3 times), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills). On 27-Mar-2021, the patient experienced ERYTHEMA (redness). On 27-Apr-2021, the patient experienced ABDOMINAL DISTENSION (abdomen is so swollen and distended) and PRURITUS (Itching). On 26-Mar-2021, SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) outcome was unknown. At the time of the report, ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), ABDOMINAL DISTENSION (abdomen is so swollen and distended), DYSPNOEA (used her inhaler 2 to 3 times), PRURITUS (Itching), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include Benadryl 50 mg every 4 hours,Tylenol as needed for fever   This case was linked to MOD-2021-091829, MOD-2021-091854 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Myalgia, Pruritus, Pyrexia
Clinical narrative: Itching; abdomen is so swollen and distended; redness; Swelling face; tight throat; Sick; Diarrhea; vomiting; Fever; Headache; Muscle pain; Chills; used her inhaler 2 to 3 times; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included ONDANSETRON HYDROCHLORIDE (ZOFRAN) for Nausea, SALBUTAMOL (ALBUTEROL) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ILLNESS (Sick), DIARRHOEA (Diarrhea), SWELLING FACE (Swelling face), THROAT TIGHTNESS (tight throat), DYSPNOEA (used her inhaler 2 to 3 times), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills). On 27-Mar-2021, the patient experienced ERYTHEMA (redness). On 27-Apr-2021, the patient experienced ABDOMINAL DISTENSION (abdomen is so swollen and distended) and PRURITUS (Itching). On 26-Mar-2021, SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) outcome was unknown. At the time of the report, ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), ABDOMINAL DISTENSION (abdomen is so swollen and distended), DYSPNOEA (used her inhaler 2 to 3 times), PRURITUS (Itching), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include Benadryl 50 mg every 4 hours,Tylenol as needed for fever   This case was linked to MOD-2021-091829, MOD-2021-091854 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Throat tightness, Vomiting
Clinical narrative: Itching; abdomen is so swollen and distended; redness; Swelling face; tight throat; Sick; Diarrhea; vomiting; Fever; Headache; Muscle pain; Chills; used her inhaler 2 to 3 times; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included ONDANSETRON HYDROCHLORIDE (ZOFRAN) for Nausea, SALBUTAMOL (ALBUTEROL) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ILLNESS (Sick), DIARRHOEA (Diarrhea), SWELLING FACE (Swelling face), THROAT TIGHTNESS (tight throat), DYSPNOEA (used her inhaler 2 to 3 times), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills). On 27-Mar-2021, the patient experienced ERYTHEMA (redness). On 27-Apr-2021, the patient experienced ABDOMINAL DISTENSION (abdomen is so swollen and distended) and PRURITUS (Itching). On 26-Mar-2021, SWELLING FACE (Swelling face) and THROAT TIGHTNESS (tight throat) outcome was unknown. At the time of the report, ILLNESS (Sick), DIARRHOEA (Diarrhea), ERYTHEMA (redness), ABDOMINAL DISTENSION (abdomen is so swollen and distended), DYSPNOEA (used her inhaler 2 to 3 times), PRURITUS (Itching), VOMITING (vomiting), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include Benadryl 50 mg every 4 hours,Tylenol as needed for fever   This case was linked to MOD-2021-091829, MOD-2021-091854 (Patient Link).